Scarica l'app Stockscreener
5.61
1.06%
-0.06
Dopo l'orario di chiusura:
5.61
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Cumberland Pharmaceuticals Inc Borsa (CPIX) Ultime notizie
Cumberland Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Brown Martin S JR - Moomoo
RedHill moves to enforce $10.9M New York judgment on Kukbo in Korea - Stock Titan
Cumberland Pharmaceuticals (CPIX) Extends Decline Amid Low Volume PressurePrice Target - newsline.com
Cumberland shares soar on $100M deal announcement - Nashville Post
Cumberland reports positive phase 2a cancer trial results - Investing.com UK
Cumberland Pharmaceuticals And Vanderbilt Announce Phase 2A Trial Data For ifetroban In High-Risk Solid Tumors - TradingView
Early trial hints at drug to cut risk of cancer returning after treatment - Stock Titan
Cumberland Pharmaceuticals and Vanderbilt Health Announce Potential New Therapy to Prevent Cancer Metastasis - Yahoo Finance
Cumberland Pharmaceuticals (CPIX) Gains Momentum: Up 2.84% on Normal Trading ActivityIV Percentile - The Legal Advocate
Cumberland Pharma Stock Rises After China Antibiotic Launch — Why Investors Are Watching - Bez Kabli
Cumberland Pharmaceuticals Hits New 52-Week High of $6.51 - MarketsMojo
CUMBERLAND PHARMACEUTICALS ANNOUNCES LAUNCH OF VIBATIV® IN CHINA - Citizen Tribune
Number of shareholders of Cumberland Pharmaceuticals Inc. – NASDAQ:CPIX - TradingView
The Zacks Analyst Blog Highlights Alphabet, Apple, Micron Technology, Cumberland Pharmaceuticals and AmeriServ Financial - Yahoo Finance
Cumberland Pharmaceuticals (CPIX) Gains Ground After Recent Decline—Key Levels in FocusHigh Low Breadth - newsline.com
CPIX Q1 2026 Earnings: Net Loss Reported, Shares Edge HigherGuidance Revision Trend - The Legal Advocate
CPIX Q1 2026 Earnings: Narrowing Losses and Strategic Progress Amidst Revenue ChallengesDividend Increase Stocks - The Legal Advocate
Cumberland Pharmaceuticals(CPIX) Stock Options Chain | Quotes & News - Moomoo
$Cumberland Pharmaceuticals (CPIX.US)$ Soaring!!!! - Moomoo
Cumberland Pharmaceuticals (NASDAQ: CPIX) to divest marketed brands to Apotex for $100M - Stock Titan
- The Legal Advocate
CPIX Q1 2026 Earnings: Loss Per Share of $0.13 as Stock Rebounds 6.5%Guidance Upgrade Report - newsline.com
Cumberland Pharmaceuticals jumps on $100M Apotex transaction - MSN
Cumberland Pharmaceuticals (CPIX) to sell U.S. brands to Apotex for $100M - Stock Titan
Cumberland outlines $100M Apotex deal while shifting to development-focused strategy - MSN
Cumberland Pharmaceuticals Inc. Q1 2026 Financial Results: Revenue, Expenses, and Company Overview - Minichart
$100M Apotex deal to reshape Cumberland (CPIX) into development player - Stock Titan
MSN Money - MSN
What Cumberland (CPIX) does that creates lasting value (Slight Dip) 2026-05-08Supply Zone - newsline.com
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q1 2026 Earnings Call Transcript - Insider Monkey
Cumberland Pharmaceuticals Divests US Portfolio to Apotex for $100 Million - HarianBasis.co
Cumberland Pharmaceuticals Pivots After Transformational Apotex Deal - TipRanks
Cumberland Posts Loss in Q1 Amid $100M Apotex Deal Plan - Yahoo Finance
Cumberland Pharmaceuticals Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Cumberland: Q1 Earnings Snapshot - theheraldreview.com
Cumberland Pharmaceuticals (NASDAQ:CPIX) Issues Earnings Results - MarketBeat
Cumberland Pharmaceuticals Sells FDA-Approved Brands for $100 Million to Apotex, Reports Q1 2026 Financial Results and Focuses on Orphan Drug Pipeline 1 - Minichart
Cumberland Pharmaceuticals Q1 Earnings Call Highlights - MarketBeat
Cumberland Pharmaceuticals Q1 revenue up 5%; to sell FDA‑approved brands to Apotex for $100 mln - TradingView
Cumberland Pharmaceuticals Inc. (CPIX) Stock Falls on Q1 2026 Earnings - Quiver Quantitative
CPIX: $100M Apotex deal and FDA approvals mark a strategic pivot to pipeline innovation - TradingView
Earnings call transcript: Cumberland Pharmaceuticals Q1 2026 shows mixed results - Investing.com
Cumberland Pharmaceuticals reports Q1 2026: $9.1M revenue, $3.3M net loss, Strategic Transaction announced - TradingView
Full Transcript: Cumberland Q1 2026 Earnings Call - Benzinga
Cumberland Pharmaceuticals (CPIX) sets $100M brand sale as Q1 2026 turns to loss - Stock Titan
$100M Apotex deal would leave Cumberland focused on orphan drugs - Stock Titan
CUMBERLAND PHARMACEUTICALS REPORTS Q1 2026 FINANCIAL RESULTS & COMPANY UPDATE - Yahoo Finance
Apotex Affiliate to Acquire Cumberland Pharmaceutical Portfolio for $100M - HarianBasis.co
Cumberland Pharmaceuticals (CPIX) Integrates Commercial Business with Apotex - Insider Monkey
Q&A: A.J. Kazimi, Cumberland Pharmaceuticals - Nashville Post
0.95%
1.13%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):